Sarepta Therapeutics SRPT shares advanced 100.20% to $30.01 at 9:45 am. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients.
BIOLASE BIOL climbed 22.29% to $2.03. BIOLASE has received clearance from the FDA and Conformité Européene Mark approval for its EPIC 10™ diode soft tissue laser.
Ocwen Financial OCN surged 15.40% to $33.42. Ocwen Financial announced its plans to acquire Homeward Residential Holdings from WL Ross & Co LLC.
BioLineRx Ltd BLRX surged 14.84% to $2.9972. BioLineRx shares have dropped 23.91% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in